IP Library Granted Patent US 12,121,228
Granted Patent B2
US 12,121,228 · App. 18/188,942 · Granted Oct 22, 2024

Expandable tissue engagement apparatus and method

Inventors: Theodore C. Lamson (Pleasanton, CA); Theodore Bender (San Anselmo, CA); Jolene Cutts (San Francisco, CA); Robert M. George (San Jose, CA); Jennifer Kiyoi (Pleasanton, CA); Daniel Merrick (Dublin, CA); Ailee Pham (Milpitas, CA); Maheshwara Rao (Oakland, CA); Christopher Zaler (Los Gatos, CA); Curtis Yarra (Oakland, CA); Kevin Alexander Lessard (San Francisco, CA)
Assignee: Teleflex Life Sciences LLC
A61B17/0218A61B17/3478A61M29/00A61B2017/00274A61B2017/00858A61B2017/00951A61B2017/0409A61B2017/22072A61B2090/0811A61M2210/166
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,121,228
App. No.
18/188,942
Granted
Oct 22, 2024
Kind
B2
Abstract

A system and associated method for manipulating tissues and anatomical or other structures in medical applications for the purpose of treating diseases or disorders or other purposes. In one aspect, the system includes an expandable structure for enhancing engagement with median lobe prostate tissue.

Claims (13)

1. A method for treating benign prostatic hyperplasia, comprising:

inserting an introducer sheath longitudinally through a urethra of a subject until at least a distal portion of the introducer sheath is positioned within a prostatic urethra;

visualizing the prostatic urethra using a cystoscope; and

advancing an elongate delivery device through the introducer sheath until at least a distal portion of the elongate delivery device extends beyond a distal opening of the introducer sheath and into a bladder, wherein the distal portion of the elongate delivery device delivers an expandable implant comprising connected curved portions that form a closed looped structure configured to engage and manipulate a prostate gland when expanded outside the introducer sheath, wherein the curved portions are biased away from a midline defined by a longitudinal axis of the elongate delivery device such that the curved portions are compressed toward the midline when positioned within the introducer sheath and expand away from the midline when positioned outside the introducer sheath.

2. The method of claim 1 , further comprising turning the elongate delivery device to align the expandable implant with a lateral prostatic lobe.

3. A method for treating benign prostatic hyperplasia, comprising:

inserting an introducer sheath longitudinally through a urethra of a subject until at least a distal portion of the introducer sheath is positioned within a prostatic urethra; and

advancing an elongate delivery device through the introducer sheath until at least a distal portion of the elongate delivery device extends beyond a distal opening of the introducer sheath into a bladder, wherein the distal portion of the elongate delivery device delivers an expandable implant comprising curved portions that form a closed looped structure configured to engage and manipulate a prostate gland when expanded, wherein the expandable implant is biased to an expanded configuration such that the expandable implant expands when positioned outside the introducer sheath and compresses when positioned within the introducer sheath, wherein at least a portion of the expandable implant is visualized using a cystoscope.

4. The method of claim 3 , further comprising visualizing at least a portion of the elongate delivery device using the cystoscope.

5. The method of claim 3 , wherein the expandable implant comprises arms and the curved portions comprise wings.

6. The method of claim 5 , wherein the curved portions, arms, or wings are connected by a distal connecting member.

7. The method of claim 5 , wherein the curved portions, arms, or wings connect at distal ends thereof to form the closed looped structure.

8. The method of claim 3 , wherein the expandable implant expands away from a longitudinal axis of the elongate delivery device when positioned outside the introducer sheath.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066617/0582 →
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066621/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066305/0073 →
MERGER Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066305/0802 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2023
From: LAMSON, THEODORE; BENDER, THEODORE; CUTTS, JOLENE; GEORGE, ROBERT; KIYOI, JENNIFER; MERRICK, DANIEL; PHAM, AILEE; RAO, MAHESHWARA; ZALER, CHRISTOPHER; YARRA, CURTIS; LESSARD, KEVIN ALEXANDER
To: NEOTRACT, INC.
Reel/Frame 063080/0508 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2023
From: NEOTRACT, INC.
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 063153/0850 →
Cited By (1)
US 12,678,308